A herbal treatment for type 2 diabetes adulterated with undisclosed drugs

Lancet. 2018 Jun 16;391(10138):2411. doi: 10.1016/S0140-6736(18)31134-6.

Authors

Mia Steyn¹, Lewis Couchman², Gemma Coombes², Kenneth A Earle¹, Atholl Johnston², David W Holt³

Affiliations

¹ Thomas Addison Unit, St George's University Hospital National Health Service Foundation Trust, London, UK.
² Analytical Services International, St George's-University of London, London SW17 0RE, UK.
³ Analytical Services International, St George's-University of London, London SW17 0RE, UK. Electronic address: david.holt@bioanalytics.co.uk.

PMID: 29916378
DOI: 10.1016/S0140-6736(18)31134-6

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Drug Contamination*
Female
Glyburide / analysis
Humans
Hypoalbuminemia / chemically induced
Hypoglycemia / chemically induced
Hypoglycemic Agents / analysis
Metformin / analysis
Middle Aged
Plant Preparations / adverse effects*
Plant Preparations / chemistry*

Substances

Hypoglycemic Agents
Plant Preparations
Metformin
Glyburide